임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
60건 표시 (상위 60건)
- 4상모집 예정· NSAID (Non-Steroidal Anti-Inflammatory Drug)Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer
리드: 대웅제약
- 4상모집 중· Type 2 Diabetes Mellitus (T2DM)Glycemic Variability of Combination Therapies in T2DM
리드: JW중외제약
- 4상모집 중· Coronary Artery DiseaseComparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
협력: 한미약품, 유한양행
- 4상모집 중· Obesity and Type 2 DiabetesEffects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
협력: 대웅제약
- 4상모집 중· Type 2 DiabetesPioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
협력: 셀트리온
- 4상모집 중· Aortic Valve StenosisENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
협력: 대웅제약
- 4상모집 중단 (진행 중)· Focal Onset SeizureOpen-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
리드: SK바이오팜
- 4상모집 중· Inflammatory Bowel DiseasesSubcutaneous Infliximab After A Previous Intravenous Dose Optimization
협력: 셀트리온
- 4상완료· Kidney TransplantMYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients
리드: 종근당
- 4상상태 미확인· Breast NeoplasmsReducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy
협력: 한미약품
- 4상모집 중단 (진행 중)· Essential HypertensionStudy to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension
리드: 유한양행
- 4상모집 중단 (진행 중)· HypercholesterolemiaLong-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides
리드: JW중외제약
- 4상상태 미확인· Essential HypertensionA Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
리드: 종근당
- 4상모집 중· Coronary Artery DiseaseHarmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
협력: 대웅제약, 한미약품, 유한양행
- 4상완료· Chronic Liver DiseaseStudy to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease
리드: 대웅제약
- 4상완료· Low-Density-Lipoprotein-Type [LDL] HyperlipoproteinemiaEffect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI
협력: 대웅제약
- 4상상태 미확인· Alzheimer DiseaseEfficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
리드: 대웅제약
- 4상모집 중단 (진행 중)· Kidney TransplantationStudy to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients
리드: 종근당
- 4상상태 미확인· Mild Cognitive ImpairmentA Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
리드: 종근당
- 4상상태 미확인· Vascular Cognitive ImpairmentA Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients
리드: 종근당
- 4상상태 미확인· Breast CancerNeoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)
협력: 삼성바이오에피스
- 4상완료· Diabetic Peripheral NeuropathyPregabalin and Alpha-lipoic Acid Combination Versus Each Monotherapy in Patients With Diabetic Peripheral Neuropathy
리드: 유한양행
- 4상상태 미확인· Liver TransplantEfficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients
리드: 종근당
- 4상상태 미확인· Kidney TransplantationEfficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients.
리드: 종근당
- 4상완료· Arterial Occlusive DiseasesClinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease
리드: 유한양행
- 4상상태 미확인· Hip FracturesIntravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery
협력: JW중외제약
- 4상완료· Liver TransplantEfficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients.
리드: 종근당
- 4상상태 미확인· Liver TransplantEfficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL)
리드: 종근당
- 4상완료· DyslipidemiasRosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
리드: 유한양행
- 4상상태 미확인· Rheumatoid ArthritisTargeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell Stratification
협력: 삼성바이오에피스
- 4상완료· Kawasaki DiseaseStudy of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease
리드: GC녹십자
- 4상완료· Non-erosive Reflux Disease(NERD)Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg
리드: 종근당
- 4상완료· Renal TransplantIVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies
협력: GC녹십자
- 4상상태 미확인· Kidney TransplantStudy to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)
리드: 종근당
- 4상완료· Type 2 DiabetesMAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes Mellitus
리드: JW중외제약
- 4상상태 미확인· Acute Upper Respiratory InfectionClinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)
리드: 한미약품
- 4상완료· Type 2 Diabetes MellitusGlucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie
협력: 종근당
- 4상완료· Atherosclerotic Cardiovascular DiseaseRosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM
리드: 유한양행
- 4상완료· Peripheral Artery Disease, PADA Study to Evaluate the Effect of Sarpogrelate on Blood Hyperviscosity
리드: 유한양행
- 4상완료· Chronic Hepatitis BClinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients
리드: 종근당
- 4상완료· Kidney TransplantStudy to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients
리드: 종근당
- 4상상태 미확인· Chronic Kidney DiseaseHMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
리드: 유한양행
- 4상상태 미확인· Alzheimer's DiseaseEffect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia
리드: 유한양행
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.